Skip to content

Biosimilars news

Biosimilars Canada has compiled a list of news stories from Canada and abroad about biosimilars that may be of interest to readers. These links to third-party websites are provided for informational purposes only, and do represent an endorsement from our organization. Biosimilars Canada’s statements and news releases are available here.

Mandatory biosimilar switching pays off for Canada

For Alberta and Green Shield Canada savings are beginning to add up from switching initiatives for multiple reference biologics, reports the American Journal of Managed Care (AJMC).

Read more

New Brunswick expands use of biosimilars to improve sustainability of public drug plans

CBC News report on the announcement of the province’s biosimilars initiative.

Read more

New Brunswick, Canada, Switches Patients to Biosimilars

Following the lead of British Columbia and Alberta, New Brunswick hopes to save on biologics, reports The Center for Biosimilars.

Read more

British Columbia switches from Humira to 5 biosimilar versions

Coverage by The Center for Biosimilars of the adalimumab phase of the BC’s biosimilars program.

Read more

Expanded access and cost savings with biosimilars

Alan Birch, RPhT provides a drug access navigator’s point of view in this Biosimilars in Oncology - Winter 2021 article. Posted with permission of Catalytic Health.

Read more

Biosimilars education initiatives by a Canadian university

Assistant Professor Kathy Vu, BSc (Pharm), PharmD highlights biosimilar education initiatives undertaken by the Leslie Dan Faculty of Pharmacy at the University of Toronto in this Biosimilars in Oncology - Winter 2021 article. Posted with permission of Catalytic Health.

Read more